Canopy Growth (CGC)
(Delayed Data from NSDQ)
$8.91 USD
+0.21 (2.41%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $8.89 -0.02 (-0.22%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth D Momentum C VGM
Brokerage Reports
0 items in cart
Canopy Growth Corporation [CGC]
Reports for Purchase
Showing records 1 - 20 ( 72 total )
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Cannabis Industry Update: 3Q23 Performance Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Weekly ReHash: Price Deflation a Needed Market Dynamic to Convert Illicit Mkt
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Weekly ReHash: Early Readthrough Into 1Q22 Confirms Industry Headwinds
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Canopy Growth Corporation
Industry: Medical - Products
Industry 1Q22 Preview: Near-Term Softness on Consumer Headwinds, 2H22 Pick Up
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Canopy Growth Corporation
Industry: Medical - Products
Consumer Weekly ReHash: Assessing 4Q21 Reports & Resetting 2022 Guidance/Outlook
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Canopy Growth Corporation
Industry: Medical - Products
Weekly ReHash: Israel - Pioneering Cannabis into a Large Market Opportunity
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Canopy Growth Corporation
Industry: Medical - Products
Weekly ReHash: Cannabis SPACs Underperformed in 2021, Reset
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Weekly ReHash: California To See Lots of Changes in 2022, Positive Developments
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Canopy Growth Corporation
Industry: Medical - Products
Weekly ReHash: MJBiz Takeaway Points Toward M&A in a Status Quo Environment
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Canopy Growth Corporation
Industry: Medical - Products
Weekly ReHash: Federal Legislation Should Start Heating Up
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S